Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

norgine - phosphate sodium monobasic - enema - 23.66 g

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

norgine - phosphate sodium monobasic - enema - 10.92 g

Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - sodium sulfate, quantity: 7.5 g; macrogol 3350, quantity: 100 g; potassium chloride, quantity: 1.015 g; ascorbic acid, quantity: 4.7 g; sodium ascorbate, quantity: 5.9 g; sodium chloride, quantity: 2.691 g - powder - excipient ingredients: acesulfame potassium; aspartame; flavour - for bowel cleansing prior to any clinical procedure requiring a clean bowel e.g. bowel endoscopy, lower gastrointestinal tract radiology or digestive tract surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - ascorbic acid, quantity: 4.7 g; sodium chloride, quantity: 2.691 g; sodium sulfate, quantity: 7.5 g; potassium chloride, quantity: 1.015 g; macrogol 3350, quantity: 100 g; sodium ascorbate, quantity: 5.9 g - powder - excipient ingredients: acesulfame potassium; aspartame; flavour - for bowel cleansing prior to any clinical procedure requiring a clean bowel e.g. bowel endoscopy, lower gastrointestinal tract radiology or digestive tract surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - rifaximin, quantity: 550 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; titanium dioxide; glyceryl diisostearate; purified talc; hypromellose; propylene glycol; disodium edetate; colloidal anhydrous silica; iron oxide red; sodium starch glycollate type a - prevention of the recurrence of hepatic encephalopathy where other treatments have failed or are contraindicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - sodium ascorbate, quantity: 48.11 g; ascorbic acid, quantity: 7.54 g - solution, powder for - excipient ingredients: - bowel cleansing prior to any procedure requiring a clean bowel.

Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - misoprostol, quantity: 25 microgram - tablet, uncoated - excipient ingredients: hypromellose; microcrystalline cellulose; maize starch; croscarmellose sodium; crospovidone; colloidal anhydrous silica - angusta is indicated for induction of labour.

Malta - English - Medicines Authority

norgine limited - potassium chloride; macrogol 3350; sodium chloride; sodium hydrogen carbonate - powder for oral solution - potassium chloride 46.6 mg; macrogol 3350 13.125 g; sodium chloride 350.7 mg; sodium hydrogen carbonate 178.5 mg - drugs for constipation

Malta - English - Medicines Authority

norgine limited - macrogol 3350; sodium chloride; sodium hydrogen carbonate; potassium chloride - powder for oral solution - macrogol 3350 6.563 g; sodium chloride 175.4 mg; sodium hydrogen carbonate 89.3 mg; potassium chloride 25.1 mg - drugs for constipation

Australia - English - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - 63185 - cognitive assessment software - liversync is an application to help monitor changes in the neurophysiological status/condition of non-hospitalised liver cirrhosis patients at risk of developing hepatic encephalopathy; it provides the patient with cognitive tests on a mobile device and the results are captured, assisting hcps to determine whether intervention is required.